On 14 November 2011 the European Commission published its decision in favour of the OatWell™ producer. The decision was in respect of Article 14 of the EC Regulation on the labelling of foodstuffs with nutrition and health claim statements permitting oat beta-glucan to be described as beneficial to health.
Following the opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA) the EFSA and the Regulation (EU) no. 1160/2011 of the Commission, foodstuffs through which 3g/day of oat beta-glucan are consumed (1g of oat beta-glucan per portion) are allowed to display the following health claim:
«Oat beta-glucan reduces the cholesterol level in the blood. The lowering of the blood cholesterol level can reduce the risk of coronary heart disease.»
Document of the EFSA: Offical-Journal-EU (700kB)